• Global market share: India dominates global medicine consumption, manufacturing 60% of medicines consumed in the US and driving trillions of dollars in healthcare savings globally.
• R&D investment: The pharmaceutical sector represents 22% of every ₹100 spent on innovation and R&D across all industries in India, leading corporate hiring of scientists and PhDs.
• Value-chain transition: Over a four-to-five-decade evolution from basic chemistry and formulations to vaccines and biologics, Indian pharma is shifting from volume-driven generics to discovery, protected IP, and higher export value.
• Zydus strategic focus: Zydus is targeting future innovation to solve unmet healthcare needs and address disease burdens across both the domestic market and Western economies.